Jincheng Heis Pharmaceutical

Jincheng Hais Pharmaceutical (also known as Jincheng Heis Pharmaceutical) is a Chinese pharmaceutical company founded in 1997 and based in Jincheng, Shanxi Province. In 2021, the company was acquired by Jiangzhong Pharmaceutical (CR Jiangzhong), a subsidiary of China Resources (CR) Pharmaceutical Group. Jincheng Hais specializes in the research, development, manufacturing, and commercialization of a wide range of pharmaceutical products, including chemical drugs and biological preparations. Its flagship products include Befida (Bifidobacterium triplex enterosoluble capsules) for gastrointestinal health and Rabeprazole Sodium Enteric-Coated Tablets for acid-related disorders. The company operates multiple GMP-certified production lines capable of manufacturing small-volume injections, lyophilized powder injections, tablets, capsules, and active pharmaceutical ingredients (APIs).